Chemical ID
HOMOHARRINGTONINE
Ubiquitous
No
Activity | Dosage | Reference |
---|---|---|
Anticarcinomic | 0.25-1 ppm | Duke, 1992 * |
Antileukemic | 1 ppm | Duke, 1992 * |
Antimalarial | not available | Nigg, H.N. and Seigler, D.S., eds. 1992. Phytochemical Resources for Medicine and Agriculture. Plenum Press, New York. 445 pp. |
Antimelanomic | ED50=0.045 ug/ml | J. Ethnopharmacology, 32: 117. |
Antisarcomic | ED50=2.15 ug/ml | J. Ethnopharmacology, 32: 117. |
Antitumor | not available | Vlietinck, A.J. and Dommisse, R.A. eds. 1985. Advances in Medicinal Plant Research. Wiss. Verlag. Stuttgart. |
Antitumor (Breast) | ED50=0.012 ug/ml | J. Ethnopharmacology, 32: 117. |
Antitumor (Colon) | ED50=0.0076 ug/ml | J. Ethnopharmacology, 32: 117. |
Antitumor (Lung) | ED50=0.019 ug/ml | J. Ethnopharmacology, 32: 117. |
Hypotensive | not available | Martindale's 29th |
MDR-Inhibitor | not available | Qian, Q. J., Han, J. L., Yan, W. W., Yang, C. Z., Han, D. S., Shi, H., Hao, Y. 1996. A Comparative Study on the Mechanism of Homoharringtonine (HHI) and Melphalan (MEL) Resistance in K562/H20 and K562/MEL Cell Lines. Zhonghua Xueyexue Zazhi,17(7):354-356. |
Tachycardic | not available | Martindale's 29th |
Plant Name | Plant Part | Low Parts Per Million | High Parts Per Million | Standard Deviation | Reference |
---|---|---|---|---|---|
Cephalotaxus drupacea | Stem | not available | not available | not available | Duke, 1992 * |
Cephalotaxus fortunei | Stem | not available | not available | not available | Duke, 1992 * |
Cephalotaxus harringtonii | Tissue Culture | 0.0 | 1.2 | not available | Duke, 1992 * |
Cephalotaxus spp | Plant | not available | not available | not available | Duke, 1992 * |